Acorda Therapeutics reported $-22864000 in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
ALKERMES ALKS:US $ -28.99M 31.35M
Amgen AMGN:US $ 1884M 1420M
Anika Therapeutics ANIK:US $ 0.56M 5.97M
Aptinyx Inc APTX:US $ -21231000 1.41M
Arrowhead Research ARWR:US $ -63374000 33.45M
Biogen BIIB:US $ 329.2M 119.3M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Clovis Oncology CLVS:US $ -67.41M 0.96M
Cytokinetics CYTK:US $ -76.09M 14.53M
Gilead Sciences GILD:US $ 2592M 1070M
GlaxoSmithKline GSK:LN 1168M 227M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Insmed INSM:US $ -112714000 4.61M
Ligand Pharmaceuticals LGND:US $ 13.72M 17M
Mannkind MNKD:US $ -4.43M 31.1M
Merck MRK:GR € 761M 16M
Moderna Inc MRNA:US 3.33B 553M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Novartis NOVN:VX SF 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Teva Pharmaceutical TEVA:IT 290M 83M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M